Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Marker Therapeutics (MRKR) Return on Assets (2016 - 2025)

Marker Therapeutics (MRKR) has disclosed Return on Assets for 11 consecutive years, with 0.1% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 1.0% to 0.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.1% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.59% for FY2025, 4.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.1% at Marker Therapeutics, up from 0.3% in the prior quarter.
  • The five-year high for Return on Assets was 0.32% in Q4 2023, with the low at 0.66% in Q1 2022.
  • Average Return on Assets over 5 years is 0.26%, with a median of 0.33% recorded in 2024.
  • The sharpest move saw Return on Assets skyrocketed 78bps in 2023, then crashed -52bps in 2024.
  • Over 5 years, Return on Assets stood at 0.56% in 2021, then grew by 26bps to 0.42% in 2022, then surged by 176bps to 0.32% in 2023, then crashed by -135bps to 0.11% in 2024, then grew by 12bps to 0.1% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.1%, 0.3%, and 0.37% for Q4 2025, Q3 2025, and Q2 2025 respectively.